Skip to content
Search

Latest Stories

No more surcharges from us, AAH Pharmaceuticals tells independent pharmacy contractors

Pledging its support to independent contractors, AAH Pharmaceuticals has announced that from today the wholesaler will not add any surcharges "to our community pharmacy customers."

An AAH spokesperson told Pharmacy Business on Dec 11: "In an effort to make it easier to do business with AAH, from today, no surcharges will be added for any reason to our community pharmacy customers. We hope this goes someway in showing our commitment not only as a business partner but to listen and support community pharmacy as a whole."


Pharmacy Businessreported on Dec 4 that independent contractors were unhappy with surcharges being applied by wholesalers during times of uncertainty. Nearly two of them said their mainline wholesalers had an unfair system of pricing for surcharges, according to a survey conducted in November by the National Pharmacy Association.

The wholesaler added: "At AAH we pride ourselves at delivering industry leading service and great value for money as part of our mission to work with customers, “creating a healthy future together”.

"We are equally as proud to be supporting our community pharmacy customers as they deliver a vital service to the nation during these uncertain times. We take our customers feedback seriously and have committed to respond with action."

Pharmacy Business reported a response from Alliance Healthcare on Dec 7 in which its spokesperson said: "As a leading pharmaceutical wholesaler, we operate a nationwide, twice-daily delivery service. To help enable us to do this we apply a low spend surcharge as per our terms and conditions.

"We work hard to ensure customers do not incur a surcharge and have a dedicated team in place that can help customers meet their qualifying spend threshold. Details of all surcharges are also available on our website, with helpful information for customers to avoid a surcharge.

"Alliance Healthcare works closely with manufacturers to ensure maximum supply of product to UK patients. In times where demand exceeds supply we may have to apply quotas to give an opportunity to all pharmacies to access stock."

The NPA survey, a smaller, snapshot survey which had 118 independent pharmacies participating, was aimed at finding out more about supply issues in the context of Covid-19.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less